Kynam Capital Management, LP - Significant Ownership

Signature - Title
Yue Tang - Managing Member
Location
Princeton, NJ
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Kynam Capital Management, LP.

Significant Ownership of Kynam Capital Management, LP

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BNR Burning Rock Biotech Ltd American Depository Shares ("ADSs") of the Issuer, each ADS representing one Class A Ordinary Share, par value $0.0002 per share 11.01% 995K Kynam Capital Management, LP Sep 30, 2025
SNDX Syndax Pharmaceuticals Inc Common Stock, par value $0.0001 per share 9.98% $95.1M 8.52M Kynam Capital Management, LP Dec 31, 2024
ENGN enGene Holdings Inc. Common Shares, no par value per share 9.8% $20M 4.99M Kynam Capital Management, LP Dec 31, 2024
CLDX Celldex Therapeutics, Inc. Common Stock, par value $0.001 9.79% $104M $22.9M 6.5M +28.4% Kynam Capital Management, LP Mar 31, 2025
STRO Sutro Biopharma, Inc. Common stock, $0.001 par value 6.44% $0 0 Kynam Capital Management, LP Mar 31, 2025
VRDN Viridian Therapeutics, Inc. Common Stock, $0.01 par value 5.76% $0 0 Kynam Capital Management, LP Mar 31, 2025
COGT Cogent Biosciences, Inc. Common Stock, par value $0.001 5.54% $113M 7.89M Kynam Capital Management, LP Sep 30, 2025
VERA Vera Therapeutics, Inc. Class A common stock, $0.001 par value per share 5.37% $75.7M 3.43M Kynam Capital Management, LP Jun 30, 2025
DVAX DYNAVAX TECHNOLOGIES CORP Common Stock, par value $0.001 per share 4.99% $85.1M 6.56M Kynam Capital Management, LP Dec 31, 2024
TSVT 2seventy Bio, Inc. Common Stock, par value $0.0001 per share 0% $0 0 Kynam Capital Management, LP Mar 11, 2025

Schedules 13D/G Reported by Kynam Capital Management, LP:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.